Colonic Diseases Clinical Trial
Official title:
Low-fiber Diet for Colorectal Cancer Screening Colonoscopy. Randomized Clinical Trial. Dietcol Study
This trial will compare the efficacy of 2 different sets of dietary recommendations to be followed before colon cleansing for colorectal cancer screening colonoscopy.
There is no enough evidence in the literature to recommend a low-fiber diet for screening
colonoscopy. Although evidence of benefit of a liquid diet is minimal and there is a growing
body of evidence about the benefits of a liberalized diet, a high degree of heterogeneity in
the clinical trials comparing the diet modifications before colonoscopy prevents a formal
recommendation in current guidelines. A low-fiber diet the day before colonoscopy may result
in same efficacy of bowel cleanliness, with an improved tolerability and acceptability.
All consecutive patients of a population-based colorectal screening cancer program referred
for a colonoscopy will be invited to participate in the study. After obtaining informed
consent, they will be randomized to one of the groups: liquid diet or low-fiber diet. The
will be interviewed by a registered research nurse, and they will be provided with written
instructions for bowel preparation and questionnaires for registering the data of the study.
The day of the colonoscopy, questionnaires will be collected and endoscopists blinded for
the study bowel preparation will perform the colonoscopy. Patients will be contacted for
adverse events and a general satisfaction questionnaire, 3 days after colonoscopy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Terminated |
NCT01119027 -
Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills
|
N/A | |
Completed |
NCT01063231 -
Evaluation of PillCamâ„¢ Colon 2 in Visualization of the Colon
|
Phase 3 | |
Completed |
NCT04074577 -
Computer Aided Detection, Tandem Colonoscopy Study
|
N/A | |
Not yet recruiting |
NCT04087824 -
Deep Learning Algorithm for Recognition of Colonic Segments.
|
N/A | |
Completed |
NCT03559543 -
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
|
Phase 2 | |
Terminated |
NCT02503631 -
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
|
||
Completed |
NCT01600209 -
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
|
N/A | |
Completed |
NCT01260168 -
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
|
N/A | |
Completed |
NCT00604162 -
PillCamâ„¢ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon
|
Phase 3 | |
Recruiting |
NCT04598880 -
Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing
|
Phase 4 | |
Completed |
NCT01738425 -
A Clinical Phase I Study on GIC-1001 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04080843 -
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
|
Phase 2 | |
Terminated |
NCT04644315 -
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
|
Phase 2 | |
Completed |
NCT02291445 -
Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study
|
Phase 2 | |
Completed |
NCT03037385 -
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03139942 -
Optical Polyp Testing for In Vivo Classification
|
N/A | |
Completed |
NCT04263818 -
Endoscopist and Endoscope Motions During Colonoscopy
|
N/A | |
Recruiting |
NCT05923918 -
A Study to Evaluate Safety and Efficacy of PBK_M2101
|
Phase 3 | |
Completed |
NCT02647866 -
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
|
Phase 2 |